Nuvation Bio's (NUVB) Outperform Rating Reiterated at Wedbush

Wedbush restated their outperform rating on shares of Nuvation Bio (NYSE:NUVB – Free Report) in a report released on Friday, Benzinga reports. The firm currently has a $5.00 price objective on the stock. Several other equities analysts also recently weighed in on NUVB. HC Wainwright reiterated a buy rating and issued a $8.00 price objective […]

Related Keywords

Canada ,Nuvation Bio ,Exchange Traded Concepts ,Susquehanna Fundamental Investments ,Nuvation Bio Inc ,Nuvation Bio Company Profile ,Jefferies Financial Group ,Beacon Pointe Advisors ,Pinnacle Wealth Planning Services Inc ,Royal Bank ,Free Report ,Financial Group ,Get Free Report ,Pointe Advisors ,Fundamental Investments ,Wealth Planning Services ,Capital Management ,Traded Concepts ,Bio Inc ,Nuvation Bio Daily ,